Using virtual reality to ease pain during port insertion for cancer patients
Utilization of Virtual Reality to Support Patient Comfort and Reduce Stress During the Implantation of a Subcutaneous Venous Port Prior to the Initiation of Oncological Treatment
This study is testing if using virtual reality can help cancer patients feel less pain and anxiety during the placement of a port for treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital Ostrava Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Ostrava, Moravian-Silesian Region) |
| Trial ID | NCT06927804 on ClinicalTrials.gov |
What this trial studies
This randomized controlled study investigates the effectiveness of virtual reality (VR) in reducing pain, anxiety, and stress during the implantation of subcutaneous venous ports in adult oncology patients. Participants will be divided into two groups: one receiving standard care and the other receiving standard care with the addition of VR intervention. Pain levels will be assessed using the Visual Analog Scale (VAS), while anxiety and stress will be measured through questionnaires and salivary cortisol levels. The goal is to validate VR as a non-pharmacological tool to enhance patient comfort during this routine procedure.
Who should consider this trial
Good fit: Ideal candidates for this study are adult oncology patients who require subcutaneous port implantation for their treatment.
Not a fit: Patients who are under 18 years of age or those unsuitable for subcutaneous port implantation may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the comfort and overall experience of patients undergoing port insertion.
How similar studies have performed: Previous studies have shown that VR can effectively reduce pain and anxiety in various medical procedures, suggesting a promising potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \> 18 years of age * Signed Informed Consent Form * Patients Indicated for oncology treatment administration using subcutaneous port Exclusion Criteria: * Not signing of the Informed Consent Form * Patients \< 18 years of age * Patients unsuitable for subcutaneous port implantation
Where this trial is running
Ostrava, Moravian-Silesian Region
- University Hospital Ostrava — Ostrava, Moravian-Silesian Region, Czechia (Recruiting)
Study contacts
- Principal investigator: Lukáš Knybel, Ing., PhD — University Hospital Ostrava
- Study coordinator: Jiří Hynčica
- Email: jiri.hyncica@fno.cz
- Phone: 0042059737
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.